OP Asset Management Ltd Invests $1.46 Million in The Cooper Companies, Inc. $COO

OP Asset Management Ltd bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the first quarter, Holdings Channel.com reports. The fund bought 20,372 shares of the medical device company’s stock, valued at approximately $1,457,000.

Several other institutional investors and hedge funds have also recently modified their holdings of COO. New York Life Investment Management LLC grew its holdings in Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares during the period. Root Financial Partners LLC raised its stake in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the period. Allworth Financial LP lifted its position in shares of Cooper Companies by 14.1% during the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after buying an additional 167 shares in the last quarter. Blue Trust Inc. increased its holdings in Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after acquiring an additional 185 shares in the last quarter. Finally, Norden Group LLC increased its holdings in Cooper Companies by 3.2% in the 4th quarter. Norden Group LLC now owns 6,634 shares of the medical device company’s stock worth $544,000 after acquiring an additional 205 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $71.39 on Tuesday. The firm has a 50-day simple moving average of $64.14 and a 200-day simple moving average of $73.56. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $13.92 billion, a price-to-earnings ratio of 60.50, a price-to-earnings-growth ratio of 1.86 and a beta of 0.88. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the business posted $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

COO has been the topic of several recent analyst reports. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. BNP Paribas Exane reduced their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.